Barba, T. et al. 2018. Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 34, 4 (Feb. 2018), 343–351. DOI:https://doi.org/10.36141/svdld.v34i4.5817.